Susan C. Lipsett

Feb 2, 2024 | jamanetwork.com | Susan C. Lipsett |Alexander Hirsch |Richard G. Bachur |Mark I. Neuman

Introduction Recent randomized clinical trials have compared antibiotic regimens of varying intensity for the treatment of pediatric community-acquired pneumonia (CAP).1-4 These trials identified no advantage to high-dose vs low-dose amoxicillin3 or a longer vs shorter duration of antibiotic therapy1-4 with respect to rates or timing of clinical improvement.